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A functional chimeric modular polyketide synthase generated via 
domain replacement 
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and Chaitan Khoslal f2~3 
Background: Modular polyketide synthases (PKSs), such as 6- 
deoxyerythronolide B synthase (DEBS), are large multifunctional enzymes that 
catalyze the biosynthesis of structurally complex and medically important natural 
products. Active sites within these assemblies are organized into ‘modules’, such 
that each module catalyzes the stereospecific addition of a new monomer onto a 
growing polyketide chain and also sets the reduction level of the P-carbon atom 
of the resulting intermediate. The core of each module is made up of a ‘reductive 
segment’, which includes all, some, or none of a set of ketoreductase (KR), 
dehydratase, and enoylreductase domains, in addition to a large interdomain 
region which lacks overt function but may contribute to structural stability and 
inter-domain dynamics within modules. The highly conserved organization of 
reductive segments within modules suggests that they might be able to function 
in unnatural contexts to generate novel organic molecules. 
Results: To investigate domain substitution as a method for altering PKS 
function, a chimeric enzyme was engineered. Using a bimodular derivative of 
DEBS (DEBSl +TE), the reductive segment of module 2, which includes a 
functional KR, was replaced with its homolog from module 3 of DEBS, which 
contains a (naturally occurring) nonfunctional KR. A recombinant strain 
expressing the chimeric gene produced the predicted ketolactone with a yield 
(35 %) comparable to that of a control strain in which the KR2 domain was 
retained but mutationally inactivated. 
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Conclusions: These results demonstrate considerable structural tolerance 
within an important segment found in virtually every PKS module. The domain 
boundaries defined here could be exploited for the construction of numerous 
loss-of-function and possibly even gain-of-function mutants within this 
remarkable family of multifunctional enzymes. 
Introduction 
Polyketides are a diverse class of natural products which 
are important as antibiotics, anti-cancer drugs, and other 
pharmacologically active agents. Biosynthesis of these 
products is achieved by the repetitive condensation of 
simple monomers in a process which closely parallels 
fatty acid biosynthesis [1,2]. In contrast to the fatty acid 
synthases (FASs), polyketide synthases (PKSs) generate 
complex products by using different carboxylic acid 
monomers and varying the degree of B-carbonyl 
reduction after each condensation. PKSs also control the 
stereochemistry of chiral carbon centers and the 
regiochemistry of cyclization(s) after chain synthesis 
[3,4]. Although the possible combinations of these 
functions could result in the formation of a vast and 
diverse collection of compounds, naturally occurring 
PKSs typically produce a single product, or small group 
of related products. The possibility of altering PKS 
function to obtain large numbers of novel compounds 
has generated considerable interest in the manipulation 
of PKSs [5,6]. 
Although this stepwise condensation of building blocks 
to form oligomers of defined ‘sequence’ is conceptually 
similar to the well-studied biosynthesis of nucleic acids 
and proteins, the synthesis of polyketides is not directed 
by a modular template. Instead, in at least some cases, 
the active sites within multifunctional PKSs themselves 
appear to be modularized. The 6-deoxyerythronolide B 
synthase (DEBS) from Sacdaropokyspora eryth-sea 
catalyzes the biosynthesis of 6-deoxyerythronolide B 
(6dEB) (l), the polyketide aglycone of the antibiotic 
erythromycin [7,8] (Fig. 1). Genetic analysis of this 
modular PKS revealed three large proteins (each with a 
molecular weight of 2300 kDa) that contain a repetitive 
series of catalytic centers homologous to FAS active 
sites: B-ketoacyl-acyl carrier protein synthase (KS), 
acyltransferase (AT), dehydratase (DH), enoyl reductase 
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Genetic model for the 6-deoxyerythronolide B synthase (DEBS). Each (ER) domains are present in the reductive segment of module 4. The 
module includes an acyltransferase (AT), a ketosynthase (KS) and an KR domain from module 3 (KR*) lacks reductase activity. The 
acyl carrier protein (ACP) domain as well as a reductive segment. The thioesterase (TE) domain, present at the carboxy-terminus of module 6, 
reductive segment minimally consists of an interdomain region (-) and catalyzes lactone formation. In S. coelicolor, DEBS produces 
a ketoreductase (KR) domain. Dehydratase (DH) and enoyl reductase 6-deoxyerythronolide B (1) as well as 8&a-deoxyoleandolide (2) [lo]. 
(ER), B-ketoreductase (KR), acyl carrier domain (ACP), 
and thioesterase (TE). Active sites are organized into 
groups called ‘modules’, such that each module 
catalyzes one cycle of condensation and B-ketoreduction 
in 6dEB biosynthesis. Thus, modular PKSs are 
strikingly similar to avian and mammalian FASs with 
respect to both the identity of active sites as well as the 
linear arrangement of these domains within each 
module. However, two key differences exist between 
modular PKSs and higher eukaryotic FASs. First, 
whereas a FAS contains a full set of reductive domains 
(KR, DH, ER), each PKS module contains only the 
subset of reductive domains required for a particular 
condensation cycle. Second, whereas a single set of 
active sites is used iteratively in FASs, the active sites in 
a PKS module participate only once during the synthesis 
of a polyketide molecule. This remarkable organization 
of DEBS and other modular PKSs suggests that it 
should be feasible to engineer these multienzyme 
systems to produce novel products. While this notion 
has been validated to some extent by deletion and site- 
directed mutagenesis [8-141, its ultimate potential 
depends upon the feasibility of constructing functional 
PKSs by domain (or module) replacement. Here we 
report a first step in this direction. 
In previous studies we have shown that a bimodular 
derivative of DEBS (designated DEBSl+TE [l&14], Fig. 
2) can accept an N-acetylcysteamine thioester of the 
diketide intermediate (compound 3, Fig. 2) and convert it 
into the expected triketide lactone 4 in the presence of 
NADPH [15]. Furthermore, in the absence of NADPH in 
the reaction mixture, the same substrate can also be 
turned over by DEBSl+TE into the expected ketolactone 
6 [16]. These in vitro results laid the groundwork for the 
experiments described here, which are aimed at 
establishing the feasibility of constructing hybrid 
modules. Specifically, we show here that it is possible to 
synthesize compound 6 in Gvo through domain 
replacement within DEBSl+TE. 
Results 
DEBSl+TE is an engineered derivative of DEBS, 
generated by fusion of the DEBSl protein, which 
contains the first two modules of DEBS, to the 
thioesterase domain from the DEBS3 protein. The 
resulting protein catalyzes the condensation of one 
equivalent of propionyl-CoA with two equivalents of 
methylmalonyl-CoA to form the triketide lactone 4. Since 
loss-of-function mutants within reductase domains have 
been engineered previously via directed mutagenesis 
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DEBSl +TE, an engineered bimodular PKS, produces the triketide 
lactones 4 and 5 in viva. The N-acetylcysteamine thioester of the 
diketide intermediate (3) is also a substrate for DEBSl +TE and is 
incorporated into 4. Incubation of DEBSI +TE with 3 and 
methylmalonyl-CoA in the absence of NADPH affords ketolactone 6. 
Substitutions to the reductive segment from module 2 were 
engineered and the compounds produced in viva were isolated. 
Introduction of the wild-type (module 2) segment resulted in the 
production of lactones 3 and 4. Ketolactones 6 and 7 were produced 
by introduction of a module 2 reductive segment bearing a 
nonfunctional KR domain. Substitution of the reductive segment from 
DEBS module 3 (KR3*) also afforded ketolactones 6 and 7. 
[8,9], a similar approach was first taken to test the 
feasibility of synthesizing 6 in z&o. A recombinant strain 
of S. coelicolor, CH999/pDB185, was constructed that 
expresses a mutant DEBSl+TE gene in which the 
second ketoreductase domain (KRZ) was inactivated by 
random PCR mutagenesis (Fig. 3). CH999/pDB185 
produces the predicted triketide ketolactone 6, which 
differs from 3 in the degree of reduction at C-3 (Fig. 2). 
In addition to the propionate primer-derived ketolactone 
6, the related acetate primer-derived compound 7 
was also obtained. 6 and 7 were produced in yields of 
20 mg 1-l and 8 mg l-l, respectively. These values are 
comparable to the yields of 4 and 5 from CH999/pDB 160. 
To test the feasibility of generating functional chimeric 
modules, the reductive segment of module 2, which 
includes a large interdomain linker as well as a KR 
domain, was replaced with the corresponding region from 
module 3 (Fig. 3). In its natural context, KR3 leaves the 
ketone at C-9 of 6-dEB unreduced. Therefore the 
chimeric PKS thus generated was expected to produce 
ketolactone 6, in which C-3 remains unreduced. Indeed, 
S. coelicolor CH999/pDB180 was found to produce 
-7 mg 1-l ketolactone 6. The related ketolactone 7 was 
also observed in smaller quantities (<a mg 1-l). No 
production of the reduced triketide lactone 4 could be 
detected by thin layer chromatography. 
Discussion 
The modular structure of DEBS provides a compelling 
model for the evolution of modular PKSs via domain 
shuffling, and raises the exciting possibility of generating 
new products in the laboratory through manipulation of 
protein domains. Previous experiments had demonstrated 
that unreduced intermediates generated by DEBS 
mutants containing inactive reductase domains would be 
faithfully processed to form the corresponding unreduced 
analogs of 6-deoxyerythronolide B [8,9]. The substitution 
of the reductive segment from module 3 for its homolog 
from module 2 in DEBSl+TE illustrates an alternative 
strategy for the construction of loss-of-function mutants in 
modular PKSs. It also demonstrates considerable 
structural tolerance within an important region found in 
virtually every PKS module. Based on comparisons with 
higher eukaryotic FASs, it was earlier speculated that the 
large interdomain linker between the AT and the KR has 
a crucial structural role and facilitates the movement of 
catalytic domains during polyketide synthesis [17]. Our 
results suggest that either this region is unimportant for 
PKS assembly and activity, or it lacks specificity and can 
therefore be substituted with equivalent interdomain 
linkers from other modules. 
Significance 
We have constructed a chimeric polyketide synthase by 
exchange of one protein domain for a homologous 
domain and demonstrated that this chimera produces 
the predicted polyketide product. The reductase region 
from DEBS module 3 was introduced in place of the 
corresponding region of module 2 in DEBSl+TE, an 
engineered bimodular PKS. This region consists of the 
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Figure 3 
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Construction of module swap mutants. The domains of the 
DEBSl +TE gene are shown approximately to scale. DNA segments 
coding for ‘linker’ segments of unknown function are shaded. PCR 
mutagenesis was used to generate plasmid pDBl60, a derivative of 
pCKI 2 [12] which contains restriction sites bordering the reductive 
segment of module 2. A Psfl site was engineered immediately 
downstream of the AT-2 domain, and an Xbal site was engineered 
immediately upstream of the ACP-2 domain. PCR primers are 
indicated with the restriction sites in bold face and mutations 
underlined. pDB185 was generated by amplifying the PsfllXbal 
fragment by random PCR mutagenesis and recloning the fragment into 
pDBl60. The reductive segment from module 3 was obtained by PCR 
amplification using primers which introduced Psfl and Xbal sites at 
homologous positions. This segment was then cloned into pDB160 to 
produce pDB180. 
ketoreductase domain in addition to a linker region of 
unknown function. The replacement of this linker 
region is a crucial prerequisite for gain-of-function 
mutagenesis, since in modules containing a full 
complement of reductive domains (e.g. module 4 of 
DEBS, Fig. 1) this interdomain linker lies nested within 
catalytic domains. Likewise, the presence of KR3 in 
DEBS module 3, despite its lack of function, suggests it 
may be important in the structural arrangement of 
enzyme domains. Our results suggest that KR3 is also 
able to fulfill this role within module 2. In conclusion, 
the domain boundaries defined here could be exploited 
for the construction of not just other loss-of-function 
mutants, but possibly even gain-of-function mutants. 
This bodes well for the future of combinatorial 
biosynthesis using this remarkable family of 
multifunctional enzymes. 
Materials and methods 
Bacterial strains and plasmids 
Streptomyces coelicolor CH999 was used as a host for the expression 
of all recombinant PKS genes. All DNA manipulations were performed 
in Escherichia co/i MC1 061. Plasmids were passaged through E. co/i 
ET1 2567 (dam, dcm hsdS Cm3 to generate unmethylated DNA prior 
to transformation into S. coelicolor. Plasmid pDB111 is a derivative of 
pCKl2 [12] which carries the DEBSl +TE gene. A Kanr cassette 
(Pharmacia GenBlock) was inserted into the unique HindIll site of 
pCKl2, giving rise to pDB1 1 1. Plasmid pDBl60 is a derivative of 
pDB1 11 in which a Pstl site has been engineered immediately 
downstream of the AT-2 domain (by mutating the sequence 
AAGCGGTICTGGCTGCTG into AAGCGGTTCTGGCTGCAG), and 
an Xbal site has been engineered immediately upstream of the ACP-2 
domain (by mutating the sequence GAGACGGAGAGCCTGCGC 
into GAGACGGAGAGCTCTAGA); both restriction sites result in the 
alteration of a single amino acid residue. Mutations were engineered by 
standard PCR mutagenesis procedures. The lack of any phenotypic 
alterations in the mutant DEBSl +TE as a result of these engineered 
sites was confirmed by in viva and in vifro analysis of 
CH999/pDBl60. Both product and protein levels in this strain were 
indistinguishable from those of CH999/pDBlll or CH999/pCK12. 
pDB180 was generated by replacing the PsfllXbal fragment of 
pDBl60, which encodes the reductive segment of module 2, with its 
homolog from module 3. The DNA encoding the reductive segment of 
module 3 was engineered as a PsfllXbal cassette based on a PILEUP 
analysis of the amino acid sequences of the DEBS modules 
(performed using University of Wisconsin, GCG software). To generate 
pDBl85, the PsfllXbal fragment of pDBl60 was amplified by random 
PCR mutagenesis 1181 using Taq polymerase for 25 cycles. Two 
independently generated PCR cassettes were tested by recloning into 
pDBl60 and transforming the resulting plasmids into CH999. One of 
the clones was found to produce compounds 6 and 7; this plasmid 
was designated pDB185. The mutation(s) in the mutant KR2 domain 
of pDBl85 were not characterized via DNA sequencing; however, 
since a full-length protein has been identified in extracts from this 
strain, a frameshift or nonsense mutation can be ruled out. 
Production and purification of polyketides 
Lawns of S. coelicolor strains CH999/pDBlll, CH999IpDB160, 
CH999/pDB180, and CH999IpDB185 were grown on R2YE agar 
plates containing 0.3 mg ml-’ sodium propionate. After seven days of 
incubation at 30 “C, the agar media (300 ml) were homogenized and 
extracted three times with 500 ml ethyl acetate. The solvent was dried 
over magnesium sulfate and concentrated. Silica gel chromatography 
(gradient of 15 to 25 % ethyl acetate in hexane) of the extracts from 
CH999/pDB180 and CH999/pDB185 afforded two products, 6 and 
7, not found in extracts of the control strains CHSSS/pDBlll or 
CH999/pDBl60 (both of which produced triketide lactone 4). 
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NMR spectroscopy and structural assigments 
NMR spectra were recorded on a Varian XL-400. Products 6 and 7 
ware spectroscopically identical to their synthetic counterparts. The 
synthesis of the C,-ketolactone 6 from 4 has been reported previously 
[I 61. To prepare authentic 7, the C, triketide lactone 5, prepared as 
previously described [i 91, was oxidized with methyl(trifluoro- 
methyhdioxirane [ZO] as described for the analogous preparation of 6. 
[I 61. As with 6, 7 is readily interconverted between the ketolactone 
and the corresponding enol-lactone tautomer. 7: Rf = 0.51 (enol- 
lactone, non-uv active, stained yellow by vanillin) and 0.26 (uv active) 
(1:i EtOAc/hexanes); ‘H NMR (CDCI,): 6 1.12 (d, J= 7.4 Hz, 3H, 
C(4)-CH,), 1.35 (d, J= 6.7 Hz, 3H, C(2)-CH,), 1.41 (d, J= 6.5 Hz, 
3H, H-6), 2.59 (dq, J=3.1, 7.6 Hz, lH, H-4), 3.59 (q, J=6.7 Hz, lH, 
H-2), 4.96 (dq, J = 3.1, 6.5 Hz, 1 H, H-5). 13C NMR: 6 8.4 (C-2 CH,), 
9.5 (C+CH,), 16.7 (C-6) 45.6 (C-4), 50.2 (C-2), 73.1 (C-5), 170.1 
(C-l), 205.2 (C-3). HRMS (El) MC calc’d for C,H,,O,: 156.0786, 
found: 156.0790. 
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